These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23915013)

  • 41. Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum.
    Kyo K; Azuma M; Okamoto K; Nishiyama M; Shimamura T; Maema A; Kanamaru H; Shirakawa M; Nakamura T; Shinmura K; Koda K; Yokoyama H
    World J Surg Oncol; 2016 Mar; 14():68. PubMed ID: 26957123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modern treatment of gastric gastrointestinal stromal tumors.
    Roggin KK; Posner MC
    World J Gastroenterol; 2012 Dec; 18(46):6720-8. PubMed ID: 23239909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laparoscopic Resection of An Extragastrointestinal Stromal Tumor in the Presacral Area.
    Sezgin B; Camuzcuoğlu A; Camuzcuoğlu H
    J Minim Invasive Gynecol; 2019; 26(5):812-813. PubMed ID: 30395935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.
    Kuroda M; Meguro N; Maeda O; Saiki S; Kinouchi T; Usami M; Kotake T
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S9-13. PubMed ID: 7527736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developments.
    Reynoso D; Trent JC
    Curr Opin Oncol; 2010 Jul; 22(4):330-5. PubMed ID: 20520542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis and multimodal therapy for extragastrointestinal stromal tumor of the prostate: A case report.
    Ou Z; Cao Z; He Y; Tang D
    Exp Ther Med; 2013 Aug; 6(2):378-380. PubMed ID: 24137192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant imatinib therapy in rectal gastrointestinal stromal tumors.
    Kaneko M; Emoto S; Murono K; Sonoda H; Hiyoshi M; Sasaki K; Shuno Y; Nishikawa T; Tanaka T; Hata K; Kawai K; Nozawa H
    Surg Today; 2019 Jun; 49(6):460-466. PubMed ID: 30443673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extragastrointestinal stromal tumor mimicking a uterine tumor. A rare clinical entity.
    Peitsidis P; Zarganis P; Trichia H; Vorgias G; Smith JR; Akrivos T
    Int J Gynecol Cancer; 2008; 18(5):1115-8. PubMed ID: 17986244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis.
    Untch M; von Minckwitz G; Konecny GE; Conrad U; Fett W; Kurzeder C; Lück HJ; Stickeler E; Urbaczyk H; Liedtke B; Beckmann MW; Salat C; Harbeck N; Müller V; Schmidt M; Hasmüller S; Lenhard M; Nekljudova V; Lebeau A; Loibl S; Fasching PA;
    Ann Oncol; 2011 Sep; 22(9):1999-2006. PubMed ID: 21382868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.
    Untch M; Fasching PA; Konecny GE; Hasmüller S; Lebeau A; Kreienberg R; Camara O; Müller V; du Bois A; Kühn T; Stickeler E; Harbeck N; Höss C; Kahlert S; Beck T; Fett W; Mehta KM; von Minckwitz G; Loibl S
    J Clin Oncol; 2011 Sep; 29(25):3351-7. PubMed ID: 21788566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of Gastrointestinal Stromal Tumors.
    Keung EZ; Raut CP
    Surg Clin North Am; 2017 Apr; 97(2):437-452. PubMed ID: 28325196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of vinorelbine, epirubicin, and cyclophosphamide as neoadjuvant chemotherapy for locally advanced breast cancer: phase II study.
    Braud AC; Levy E; Feuilhade F; Otmezguine Y; Calitchi E; Kirova Y; Le Bourgeois JP
    Am J Clin Oncol; 2002 Jun; 25(3):303-7. PubMed ID: 12040294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary prostatic extragastrointestinal stromal tumor: a case report and literature review.
    You YH; Zhang Y
    J Int Med Res; 2018 Oct; 46(10):4343-4349. PubMed ID: 30152251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extragastrointestinal Stromal Tumor (EGIST): A 16-Year Experience of 13 Cases Diagnosed at a Single Center.
    Hatipoğlu E
    Med Sci Monit; 2018 May; 24():3301-3306. PubMed ID: 29777611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rare case of extraluminal gastrointestinal stromal tumor of the ileum presenting with lower urinary tract symptoms: A case report.
    Yu CH; Ting HK; Kao CC; Tsai WC; Wu ST; Yu DS
    Medicine (Baltimore); 2019 Dec; 98(49):e18103. PubMed ID: 31804320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A Large Gastric Gastrointestinal Stromal Tumor Successfully Treated with Neoadjuvant Imatinib Followed by Surgery-A Case Report].
    Oguri Y; Cho H; Oohinata R; Onoyama H; Horiguchi S
    Gan To Kagaku Ryoho; 2019 Aug; 46(8):1307-1309. PubMed ID: 31501376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Robot-assisted laparoscopic excision of a pelvic extragastrointestinal stromal tumor: a case report and literature review.
    Liao JM; Mayer WA; Kim MM; Link RE
    Can J Urol; 2011 Jun; 18(3):5731-4. PubMed ID: 21703050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response Assessment of Recurrent Extragastrointestinal Stromal Tumor of the Urinary Bladder to Imatinib: Findings on Serial
    Tripathy S; Arun Raj ST; Prakash S; Thanaignathan T; Shamim SA
    Indian J Nucl Med; 2020; 35(4):350-352. PubMed ID: 33642766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
    Smith JW; Buyse ME; Rastogi P; Geyer CE; Jacobs SA; Patocskai EJ; Robidoux A; Conlin AK; Ansari B; Keogh GP; Stella PJ; Gross HM; Lord RS; Polikoff JA; Mauquoi C; Mamounas EP; Swain SM; Wolmark N
    Clin Breast Cancer; 2017 Feb; 17(1):48-54.e3. PubMed ID: 27693116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant Imatinib.
    Brown JB; Pai RK; Burgess MA; Chennat J; Zureikat AH
    J Natl Compr Canc Netw; 2018 Dec; 16(12):1424-1428. PubMed ID: 30545989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.